menu
    • menu

    Company profile for Biorestorative Therapies

    NEW Drugs in Dev: 2
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    BioRestorative Therapies was founded by scientists and researchers committed to developing stem cell therapies to address unmet needs in patients with highly prevalent conditions. Our advances in stem cell biology and delivery protocols harbor great promise in conditioning our bodies’ own regenerative potential to treat major diseases more effectively than current interventions.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Biorestorative TherapiesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    40 Marcus Drive Suite One Melville, NY 11747
    Telephone
    Telephone
    (631) 760-8100
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.biorestorative.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Asia Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    Asia Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BioRestorative Therapies Joins Be+Well Show in NYC, March 8-10
    BioRestorative Therapies Joins Be+Well Show in NYC, March 8-10

    05 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/05/3250074/0/en/BioRestorative-Therapies-Inc-to-Participate-in-the-Be-Well-Beauty-and-Wellness-Show-in-New-York-City-March-8-10-2026.html

    GLOBENEWSWIRE
    05 Mar 2026
    Share Share
    Biorestorative Therapies Issues Shareholder Letter On Milestones
    Biorestorative Therapies Issues Shareholder Letter On Milestones

    04 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/04/3249324/0/en/BioRestorative-Therapies-Inc-Issues-Letter-to-Shareholders-Highlighting-Major-Milestones-Regulatory-Alignment-Clinical-Execution-and-Capital-Strategy.html

    GLOBENEWSWIRE
    04 Mar 2026
    Share Share
    BioRestorative Bolsters Global IP Portfolio for ThermoStem
    BioRestorative Bolsters Global IP Portfolio for ThermoStem

    24 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/24/3243595/0/en/BioRestorative-Expands-Global-Protection-for-ThermoStem-a-Potentially-Longer-Lasting-and-Safer-Cell-Based-Alternative-to-GLP-1-Drugs.html

    GLOBENEWSWIRE
    24 Feb 2026
    Share Share
    BioRestorative Announces Closing Of $5.0 Million Public Offering
    BioRestorative Announces Closing Of $5.0 Million Public Offering

    13 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/14/3238387/0/en/BioRestorative-Announces-Closing-of-5-0-Million-Public-Offering.html

    GLOBENEWSWIRE
    13 Feb 2026
    Share Share
    Biorestorative Finishes Phase 2 Trial Enrollment For BRTX-100
    Biorestorative Finishes Phase 2 Trial Enrollment For BRTX-100

    10 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/10/3235257/0/en/BioRestorative-Completes-Patient-Enrollment-in-Landmark-Phase-2-Trial-of-BRTX-100-for-Chronic-Lumbar-Disc-Disease.html

    GLOBENEWSWIRE
    10 Feb 2026
    Share Share
    FDA Grants Type B Meeting for BioRestorative's BRTX-100 BLA
    FDA Grants Type B Meeting for BioRestorative's BRTX-100 BLA

    17 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/17/3188970/0/en/BioRestorative-Granted-Type-B-Meeting-with-FDA-to-Discuss-Accelerated-BLA-Approval-Pathway-for-BRTX-100-in-Chronic-Lumbar-Disc-Disease.html

    GLOBENEWSWIRE
    17 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search